Advanced Enzyme Q4 FY26 Results: Revenue Growth Outlook

Posted by : Neeraj Pandey | Tue Mar 10 2026

Advanced Enzyme Technologies Q4 FY26 results date is all set to be announced soon and most investors are awaiting it. Professionals are expecting an increase in revenue due to higher sales and a significant rise in PAT. Advanced Enzyme Technologies was listed on the National Stock Exchange (NSE) on 01-Aug-2016. Advanced Enzyme Technologies share has its face value of 2 per share, and its NSE symbol is ADVENZYMES. The company operates in the Healthcare sector and primarily belongs to the Biotechnology industry.

Table of Contents

Advanced Enzyme Technologies Q4 Results 2026 Preview

Advanced Enzyme Technologies Q4 FY26 revenue is expected to be around Moderate Growth Expected, representing a 9-12% YoY increase compared to the same quarter last year.
Profit After Tax, or PAT, is projected to rise 10-14% YoY.
EBITDA to rise 11%.
Advanced Enzyme Technologies is expected to show Moderate Growth Expected in its revenue.

Click and Sign Up to Get Live Updates on Q4 Results

Advanced Enzyme Technologies Share Performance

Over the past six months, Advanced Enzyme Technologies share price has 18% by 9-13% to 297.5.
Moreover, over the past year, the stock has 30% by Up
Despite this weak short-term performance, Advanced Enzyme Technologies stock has delivered a financially sound 140% return over the past 5 years.
As of today, 10-03-2026, the Advanced Enzyme Technologies share price is trading at 297.5 per share.

Key Factors to Watch for Advanced Enzyme Technologies Q4 Results FY26

Revenue Growth & Segment Performance – Focus on topline growth in the Biotechnology industry within the Healthcare sector.
Occupancy Levels & Seat Expansion – Monitor operational expansion and capacity utilisation trends.
Profitability & Margin Trends – Track EBITDA and PAT margins to evaluate cost control and operating efficiency.
Order Book & New Client Wins – Watch for updates on new contracts, partnerships, and long-term deals.
Balance Sheet & Cash Flow Position – Review debt levels, working capital management, and operating cash flows for financial stability.

About Advanced Enzyme Technologies

Advanced Enzyme Technologies is a biotechnology company focused on developing and manufacturing enzyme-based solutions for sectors including pharmaceuticals, food, animal nutrition, and textiles, serving global markets as a leading provider of specialty enzyme products.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Final Thoughts

Advanced Enzyme Technologies is gear up to announce its Q4 FY26 results. Analysts expect 9-12% revenue growth, a 10-14% rise in PAT, and a 11% rise in EBITDA. Advanced Enzyme Technologies focuses on revenue growth from order execution, margin improvement, a strong order book, and management.

Stay informed with Univest blogs to get real-time updates on Advanced Enzyme Technologies Q4 results FY26.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.